Seelos Therapeutics, Inc. Common Stock
SEEL
SEEL was delisted on the 15th of October, 2024.
2 hedge funds and large institutions have $7.03M invested in Seelos Therapeutics, Inc. Common Stock in 2014 Q2 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
81% more call options, than puts
Call options by funds: $738K | Put options by funds: $408K
2% more capital invested
Capital invested by funds: $6.92M → $7.03M (+$111K)
0% more funds holding
Funds holding: 2 → 2 (0)
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DIA
Denver Investment Advisors
Denver,
Colorado
|
-$150K |
| 2 |
VKH
Virtu KCG Holdings
New York
|
-$38K |
| 3 |
Goldman Sachs
New York
|
-$28K |
| 4 |
Millennium Management
New York
|
-$24K |
| 5 |
WA
WFG Advisors
Dallas,
Texas
|
-$21K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
HDIM
26
Hanson & Doremus Investment Management
Burlington,
Vermont
| $2K | – | – | – |
|
|
TRCT
27
Tower Research Capital (TRC)
New York
| $2K | – | – | – |
|
28
BNP Paribas Financial Markets
Paris,
France
| $486 | – | – | – |
|
29
Bank of America
Charlotte,
North Carolina
| – | -$2K | – | – |
|
|
DIA
30
Denver Investment Advisors
Denver,
Colorado
| – | -$150K | – | – |
|
|
31
Goldman Sachs
New York
| – | -$28K | – | – |
|
|
HI
32
Hudock Inc
Williamsport,
Pennsylvania
| – | -$1K | – | – |
|
|
33
Millennium Management
New York
| – | -$24K | – | – |
|
|
VKH
34
Virtu KCG Holdings
New York
| – | -$38K | – | – |
|
|
WA
35
WFG Advisors
Dallas,
Texas
| – | -$21K | – | – |
|
SEEL Hedge Fund Activity: Q2 2014 in Review
2 of the 3,480 institutional investors tracked by Wall St. Rank reported a position in Seelos Therapeutics, Inc. Common Stock (SEEL) for Q2 2014, worth a combined $7.03M — up 1.6% from $6.92M a quarter earlier.
Fund positioning in SEEL was balanced in Q2 2014: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.
The largest seller was Denver Investment Advisors, cutting an estimated $150K.
- 2 institutional investors held Seelos Therapeutics, Inc. Common Stock (SEEL) as of Q2 2014, unchanged from Q1 2014.
- Funds reported $7.03M of Seelos Therapeutics, Inc. Common Stock stock for Q2 2014, up 1.6% quarter-over-quarter.
- 0 funds opened new Seelos Therapeutics, Inc. Common Stock positions in Q2 2014 and 0 closed out.
- The largest Seelos Therapeutics, Inc. Common Stock seller in Q2 2014 was Denver Investment Advisors, an estimated $150K sold.
Based on aggregated 13F filings for Q2 2014.